Strengthening tuberculosis clinical trial implementation: operational challenges, lessons learned, and consensus recommendations from a Delphi study
Year: 2026
Type: article
Abstract: Tuberculosis (TB) remains a major global public health challenge, and most TB clinical trials are conducted in high-burden settings where operational constraints—ranging from fragile infrastructure to complex regulatory landscapes—frequently undermine trial efficiency and data quality. Despite an expanding research pipeline, there is a lack of harmonized operational guidance to manage these recurring obstacles. This study aimed to identify key operational challenges in TB clinical trials, including trials of treatment regimens, diagnostics, and other TB-related interventions, and to develop consensus-based recommendations to strengthen their implementation, particularly within or in close coordination with public health systems. We conducted a modified electronic Delphi (e-Delphi) study in accordance with ACCORD reporting guidelines. Operational challenges were first identified through an international workshop involving experienced investigators, trial managers, laboratory specialists, and policy experts from the SMA-TB and ADVANCE-TB consortia. These insights were synthesized into seven operational domains, from which 14 draft recommendations were developed. An international, multidisciplinary expert panel evaluated the recommendations through an anonymized, structured consensus process. All 14 recommendations reached high consensus (87.5%–100% agreement) in a single Delphi round. The resulting roadmap comprises seven interrelated domains: (1) trial design and protocol flexibility; (2) proactive regulatory/ethical engagement; (3) participant-centered recruitment and retention; (4) standardized data collection and quality systems; (5) laboratory infrastructure and workforce resilience; (6) robust statistical analysis planning; and (7) transparent operational governance. Qualitative feedback emphasized the need for balancing methodological standardization with context-sensitive flexibility, particularly in crisis-affected, under-resourced, or politically unstable settings. This consensus-based roadmap consolidates field-derived experience into actionable operational recommendations to strengthen the resilience, efficiency, and ethical robustness of TB clinical trials, particularly in high-burden LMIC settings. By addressing structural and operational barriers that disproportionately affect resource-limited contexts, these recommendations are relevant to trialists, funders, regulators, and national TB programs seeking to improve equity, generalizability, and policy relevance of trial evidence. Wider adoption may support more timely and robust evaluation of new TB interventions and accelerate their translation into public health practice.
Source: BMC Public Health
Authors: Ayoub Ez-Zari, Cristina Prat Aymerich, Cristina Celan, Sergio Díaz-Fernández, Andrii Dudnyk, Roser Escrig-Sarreta, Judith Farrés, Lorenzo Guglielmetti, Gunar Günther, Olha Konstantynovska, Zorica Nanovic, Jérôme Nigou, Margarida Saraiva, Sofia Samper, Helen Rose Savage, Albert Tuldrà, Nestani Tukvadze, Violeta Valcheva, Sebastià Videla, Alicia Lacoma, Lilibeth Arias, Cristina Vilaplana
Institutions: Abdelmalek Essaâdi University, Utrecht University, University Medical Center Utrecht, Ecraid Foundation (Netherlands), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, National Pirogov Memorial Medical University, Vinnytsya, Hospital Universitari Germans Trias i Pujol, Fundació Lluita contra les Infeccions, University of Bern, University Hospital of Bern, Imperial College London, V. N. Karazin Kharkiv National University, Goce Delcev University, Centre National de la Recherche Scientifique, Université Toulouse III - Paul Sabatier, Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, Universidade do Porto, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto Aragonés de Ciencias de la Salud, North Bristol NHS Trust, Swiss Tropical and Public Health Institute, National Center for Tuberculosis and Lung Disease, Bulgarian Academy of Sciences, Stephan Angeloff Institute of Microbiology
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,290
OpenAlex ID: W7215040342
